SERA vs HLVX
Comparison between Sera Prognostics Inc Class A (SERA, Company) and HilleVax Inc (HLVX, Company).
Both SERA and HLVX are from the Healthcare sector.
SERA vs HLVX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
SERA
$105M
Winner
HLVX
$105M
Max Drawdown
Winner
SERA
91.10%
HLVX
93.71%
Sharpe Ratio
SERA
-0.03
Winner
HLVX
0.44
5Y Beta
SERA
1.09
HLVX
N/A
Industry
SERA
Medical Devices
HLVX
Biotechnology
P/E Ratio
Winner
SERA
-3.04
HLVX
-1.45
Debt to Equity
SERA
0.00%
HLVX
0.00%
Free Cash Flow Yield
Winner
SERA
-26.38%
HLVX
-57.13%
P/S Ratio
SERA
1428.95
HLVX
N/A
P/B Ratio
SERA
1.33
Winner
HLVX
0.71
SERA vs HLVX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
SERA
+17.93%
HLVX
+1.46%
3M
SERA
+2.36%
Winner
HLVX
+12.97%
6M
SERA
-33.02%
Winner
HLVX
+18.08%
1Y
SERA
-30.23%
Winner
HLVX
+15.47%
5Y(CAGR)
SERA
-26.33%
HLVX
N/A
Max(CAGR)
Winner
SERA
-28.75%
HLVX
-47.96%
SERA vs HLVX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | SERA | HLVX |
|---|---|---|
| 2026 | -27.67% | N/A |
| 2025 | -64.59% | +0.48% |
| 2024 | +36.35% | -86.39% |
| 2023 | +356.49% | +6.29% |
| 2022 | -83.57% | -12.36% |
| 2021 | -42.27% | N/A |
SERA vs HLVX Drawdown Comparison
The maximum drawdown for SERA was -91.10%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The maximum drawdown for HLVX was -93.71%, occurring on Apr 1, 2025. This drawdown has not yet recovered.
The current SERA drawdown is -83.36%. The current HLVX drawdown is -90.50%.
| Rank | SERA | HLVX |
|---|---|---|
| #1 | -91.10% Aug 9, 2021 - Dec 28, 2022 | -93.71% Sep 13, 2022 - Apr 1, 2025 |
| #2 | -23.11% Jul 15, 2021 - Aug 2, 2021 | -56.89% May 3, 2022 - Sep 13, 2022 |
| #3 | -8.00% Aug 2, 2021 - Aug 5, 2021 | N/A |
Correlation
Correlation between SERA and HLVX is -0.23 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.23
-101
Select Stocks to Compare
Popular: SERA vs SPYHLVX vs SPY
More Comparisons
Compare with similar stocks